|
|
||||||||
GROWTH, DIFFERENTIATION, AND APOPTOSIS
1Central Texas Veterans Health Care System, 2Department of Medicine and 3Systems Biology and Translational Medicine, 4Division of Research and Education, 5Division of Molecular Cardiology, Scott & White and Texas A&M Health Science Center, College of Medicine, Temple, Texas; 6Department of Human Anatomy, University of Rome, "La Sapienza," Rome; 7Division of Gastroenterology, Tohoku University Hospital, Aobaku, Sendai, Japan; 8Department of Experimental Medicine, State University of l'Aquila, l'Aquila; and 9Department of Gastroenterology, Università Politecnica delle Marche, Ancona, Italy
Submitted 16 August 2007 ; accepted in final form 21 May 2008
Cholangiopathies are characterized by the heterogeneous proliferation of different-sized cholangiocytes. Large cholangiocytes proliferate by a cAMP-dependent mechanism. The function of small cholangiocytes may depend on the activation of inositol trisphosphate (IP3)/Ca2+-dependent signaling pathways; however, data supporting this speculation are lacking. Four histamine receptors exist (HRH1, HRH2, HRH3, and HRH4). In several cells: 1) activation of HRH1 increases intracellular Ca2+ concentration levels; and 2) increased [Ca2+]i levels are coupled with calmodulin-dependent stimulation of calmodulin-dependent protein kinase (CaMK) and activation of cAMP-response element binding protein (CREB). HRH1 agonists modulate small cholangiocyte proliferation by activation of IP3/Ca2+-dependent CaMK/CREB. We evaluated HRH1 expression in cholangiocytes. Small and large cholangiocytes were stimulated with histamine trifluoromethyl toluidide (HTMT dimaleate; HRH1 agonist) for 24–48 h with/without terfenadine, BAPTA/AM, or W7 before measuring proliferation. Expression of CaMK I, II, and IV was evaluated in small and large cholangiocytes. We measured IP3, Ca2+ and cAMP levels, phosphorylation of CaMK I, and activation of CREB (in the absence/presence of W7) in small cholangiocytes treated with HTMT dimaleate. CaMK I knockdown was performed in small cholangiocytes stimulated with HTMT dimaleate before measurement of proliferation and CREB activity. Small and large cholangiocytes express HRH1, CaMK I, and CaMK II. Small (but not large) cholangiocytes proliferate in response to HTMT dimaleate and are blocked by terfenadine (HRH1 antagonist), BAPTA/AM, and W7. In small cholangiocytes, HTMT dimaleate increased IP3/Ca2+ levels, CaMK I phosphorylation, and CREB activity. Gene knockdown of CaMK I ablated the effects of HTMT dimaleate on small cholangiocyte proliferation and CREB activation. The IP3/Ca2+/CaMK I/CREB pathway is important in the regulation of small cholangiocyte function.
heterogeneity; calcium; intrahepatic biliary epithelium; mitosis; transcription factors
This article has been cited by other articles:
![]() |
H. Francis, P. Onori, E. Gaudio, A. Franchitto, S. DeMorrow, J. Venter, S. Kopriva, G. Carpino, R. Mancinelli, M. White, et al. H3 Histamine Receptor-Mediated Activation of Protein Kinase C{alpha} Inhibits the Growth of Cholangiocarcinoma In vitro and In vivo Mol. Cancer Res., October 1, 2009; 7(10): 1704 - 1713. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Mancinelli, P. Onori, E. Gaudio, S. DeMorrow, A. Franchitto, H. Francis, S. Glaser, G. Carpino, J. Venter, D. Alvaro, et al. Follicle-stimulating hormone increases cholangiocyte proliferation by an autocrine mechanism via cAMP-dependent phosphorylation of ERK1/2 and Elk-1 Am J Physiol Gastrointest Liver Physiol, July 1, 2009; 297(1): G11 - G26. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |